JESSICA SENTELL: Open Payments
NPI 1427674282 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,524 in 149 payments from 20 companies in 2025. Trend: 2023 $768 · 2024 $929 · 2025 $2,524
Food & beverage: $2,425Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $620 |
| Janssen Biotech, Inc. | 26 | $342 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $207 |
| Celltrion USA Inc. | 6 | $180 |
| GENZYME CORPORATION | 9 | $176 |
| Ipsen Biopharmaceuticals, Inc | 6 | $138 |
| Regeneron Healthcare Solutions, Inc. | 5 | $137 |
| Madrigal Pharmaceuticals | 6 | $118 |
| Intercept Pharmaceuticals, Inc. | 6 | $107 |
| Gilead Sciences, Inc. | 5 | $93 |
Products named: TREMFYA, DUPIXENT, RINVOQ, CREON, ENTYVIO, ZYMFENTRA, SKYRIZI, REZDIFFRA.
Industry payments across SC — which companies pay providers there.
